title: m-TOR inhibitor as potential radiosensitizer for head and neck squamous cell carcinoma: A case report of an organ transplant patient and review of the literature.
authors: Department of Medical Oncology, Saint-André Hospital, University Hospital, CHU Bordeaux, France; Bordeaux University, Bordeaux, France. Electronic address: amaury.daste@chu-bordeaux.fr.
authors: Amaury
authors: A
authors: Daste
authors: Department of Otolaryngology - Head and Neck Surgery, Pellegrin Hospital, University Hospital, CHU Bordeaux, France.
authors: Erwan
authors: E
authors: de Mones
authors: Department of Radiation Therapy, Haut Leveque Hospital, University Hospital, CHU Bordeaux, France.
authors: Charles
authors: C
authors: Dupin
authors: Department of Medical Oncology, Saint-André Hospital, University Hospital, CHU Bordeaux, France; Bordeaux University, Bordeaux, France.
authors: Louis
authors: L
authors: François
authors: Department of Medical Oncology, Saint-André Hospital, University Hospital, CHU Bordeaux, France; Bordeaux University, Bordeaux, France.
authors: Alain
authors: A
authors: Ravaud
authors: Department of Medical Oncology, Saint-André Hospital, University Hospital, CHU Bordeaux, France.
authors: Laurence
authors: L
authors: Digue
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D059248:Chemoradiotherapy / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016030:Kidney Transplantation; D007822:Laryngeal Neoplasms / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D020123:Sirolimus / Q000494:pharmacology / Q000627:therapeutic use*; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors*
chemical_list: D007166:Immunosuppressive Agents; D011838:Radiation-Sensitizing Agents; C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases; D020123:Sirolimus
keywords: Cetuximab; Head and neck squamous cell carcinoma; Organ transplant; Radiation skin toxicity; m-TOR inhibitor